Please login to the form below

Not currently logged in
Email:
Password:

economics

This page shows the latest economics news and features for those working in and with pharma, biotech and healthcare.

ICER closely monitoring FDA’s Zolgensma investigation

ICER closely monitoring FDA’s Zolgensma investigation

Could affect initial cost assessment. Following an announcement by the FDA that it is investigating ‘data manipulation’ of Novartis’ Zolgensma, the Institute for Clinical and Economic Review (ICER) has commented that

Latest news

More from news
Approximately 5 fully matching, plus 978 partially matching documents found.

Latest Intelligence

  • Biotech profile: Tom Evans, CEO, Vaccitech.

    We’ve reached a state in which influenza peaks seasonally and leads to global health and economic costs through lost productivity and even death, while the risk of a global pandemic

  • 25 Women Leaders in UK Healthcare (part 2) 25 Women Leaders in UK Healthcare (part 2)

    There is ample evidence that greater diversity (in gender, ethnicity and socio-economic background) helps to create more successful businesses, but these cultural shifts take time and determination to bring about.

  • Evolving behaviour change Evolving behaviour change

    It also looks at economics and sociology to shed light on the behaviour of populations.

  • It’s not the end of the world, is it? It’s not the end of the world, is it?

    There are very good social, political, economic and technological reasons that every one of the examples that emerges from my work is unlikely to happen.

  • Gene therapy market access Q&A Gene therapy market access Q&A

    Jesper Jorgensen, Health Economics and Market Access Manager, Cell and Gene Therapy Catapult. ... and the role of the Health Economics and Market Access function is to provide expertise around commercialisation and market access issues.

More from intelligence
Approximately 2 fully matching, plus 204 partially matching documents found.

Latest appointments

  • Paris biocluster appoints Stéphane Roques as new chief Paris biocluster appoints Stéphane Roques as new chief

    I am convinced that the convergence of their common interests can shape a new world and be a source of economic and societal value.

  • Claes Buxfeldt joins NDA Claes Buxfeldt joins NDA

    He has represented the payer voice in development programmes including the development of payer evidence strategies, pricing, market access strategy, economic models and clinical programme input.

  • Future Thinking appoints Mohamed Muhsin as UK pharma head Future Thinking appoints Mohamed Muhsin as UK pharma head

    Both Muhsin and Bonrepaux-Caux will be focusing on expanding Future Thinking’s global footprint, technical capabilities and will be leveraging the company’s heritage in primary market research, behavioral economics

  • Vintura appoints Lieven Annemans as an associate partner Vintura appoints Lieven Annemans as an associate partner

    He will advise the consultancy's clients on market access issues. Healthcare and life sciences consultancy firm Vintura has appointed health-economics professor Lieven Annemans as an associate partner after previously ... Bas Amesz, partner at Vintura,

  • VCLS appoints Carole Jones to senior market access role VCLS appoints Carole Jones to senior market access role

    her focus on expanding the company’s market access capabilities, spanning payer strategy, health economics and outcomes research (HEOR), health technology assessment (HTA) and communications support. ... The combination of world class regulatory and

More from appointments
Approximately 0 fully matching, plus 34 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 6 fully matching, plus 125 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics